Paul J. Mellett
2021
Compensation breakdown
Non-Equity Incentive Plan | $192,803 |
---|---|
Option Awards | $652,535 |
Salary | $440,381 |
Stock Awards | $582,640 |
Other | $19,211 |
Total | $1,887,570 |
Mellett received $652.5K in option awards, accounting for 35% of the total pay in 2021.
Mellett also received $192.8K in non-equity incentive plan, $440.4K in salary, $582.6K in stock awards and $19.2K in other compensation.
Rankings
In 2021, Paul J. Mellett's compensation ranked 6,264th out of 12,415 executives tracked by ExecPay. In other words, Mellett earned more than 49.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,264 out of 12,415 | 50th |
Division Manufacturing | 2,663 out of 5,508 | 52nd |
Major group Chemicals And Allied Products | 1,169 out of 2,378 | 51st |
Industry group Drugs | 1,040 out of 2,099 | 51st |
Industry Pharmaceutical Preparations | 752 out of 1,549 | 52nd |
Pay ratio
Paul J. Mellett's Pay | $1,887,570 |
---|---|
Median Employee's Pay | $230,731 |
Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Paul J. Mellett was $1,887,570.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $230,731.
The ratio of Paul J. Mellett's pay to the pay of median employee was therefore 8 to one.
Mellett's colleagues
We found five more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2021.
2021
Jay Luly
Enanta Pharmaceuticals
Chief Executive Officer
2021
Brendan Luu
Enanta Pharmaceuticals
Senior Vice President, Business Development
2021
Tara Kieffer
Enanta Pharmaceuticals
Senior Vice President, New Product Strategy & Development
2021
Yat Or
Enanta Pharmaceuticals
Chief Scientific Officer
2021
Nathaniel Gardiner
Enanta Pharmaceuticals
General Counsel
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019